Revenio Group Oyj Third Quarter 2024 Earnings: Misses Expectations

Revenio Group Oyj (HEL:REG1V) Third Quarter 2024 Results

Key Financial Results

• Revenue: €23.9m (up 8.6% from 3Q 2023).
• Net income: €4.20m (down 6.7% from 3Q 2023).
• Profit margin: 18% (down from 21% in 3Q 2023). The decrease in margin was driven by higher expenses.
• EPS: €0.16 (down from €0.17 in 3Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Revenio Group Oyj Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 4.9%. Earnings per share (EPS) also missed analyst estimates by 22%.

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Medical Equipment industry in Finland.

Performance of the Finnish Medical Equipment industry.

The company's shares are down 7.0% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Revenio Group Oyj's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.